Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index; none of the 34 sources its claims cite is checked for support yet.
Abstract
AIMS/HYPOTHESIS: Human pancreatic beta cells may be complicit in their own demise in type 1 diabetes, but how this occurs remains unclear. One potentially contributing factor is hyperexpression of HLA class I antigens. This was first described approximately 30 years ago, but has never been fully characterised and was recently challenged as artefactual. Therefore, we investigated HLA class I expression at the protein and RNA levels in pancreases from three cohorts of patients with type 1 diabetes. The principal aims were to consider whether HLA class I hyperexpression is artefactual and, if not, to determine the factors driving it. METHODS: Pancreas samples from type 1 diabetes patients with residual insulin-containing islets (n = 26) from the Network for Pancreatic Organ donors with Diabetes (nPOD), Diabetes Virus Detection study (DiViD) and UK recent-onset type 1 diabetes collections were immunostained for HLA class I isoforms, signal transducer and activator of transcription 1 (STAT1), NLR family CARD domain containing 5 (NLRC5) and islet hormones. RNA was extracted from islets isolated by laser-capture microdissection from nPOD and DiViD samples and analysed using gene-expression arrays. RESULTS: Hyperexpression of HLA class I was observed in the insulin-containing islets of type 1 diabetes patients from all three tissue collections, and was confirmed at both the RNA and protein levels. The expression of β2-microglobulin (a second component required for the generation of functional HLA class I complexes) was also elevated. Both 'classical' HLA class I isoforms (i.e. HLA-ABC) as well as a 'non-classical' HLA molecule, HLA-F, were hyperexpressed in insulin-containing islets. This hyperexpression did not correlate with detectable upregulation of the transcriptional regulator NLRC5. However, it was strongly associated with increased STAT1 expression in all three cohorts. Islet hyperexpression of HLA class I molecules occurred in the insulin-containing islets of patients with recent-onset type 1 diabetes and was also detectable in many patients with disease duration of up to 11 years, declining thereafter. CONCLUSIONS/INTERPRETATION: Islet cell HLA class I hyperexpression is not an artefact, but is a hallmark in the immunopathogenesis of type 1 diabetes. The response is closely associated with elevated expression of STAT1 and, together, these occur uniquely in patients with type 1 diabetes, thereby contributing to their selective susceptibility to autoimmune-mediated destruction.
Overview
CoChat Summary
TL;DR
This study reports that islet-cell HLA class I hyperexpression is real, reproducible across three type 1 diabetes pancreas cohorts, and present at both protein and RNA levels. The hyperexpression is associated with elevated STAT1, not NLRC5, and is strongest in insulin-containing islets near diagnosis, then declines with disease duration.
Key findings
- HLA class I hyperexpression was observed in insulin-containing islets from all three cohorts and was not seen in controls; it was restricted mainly to insulin-containing islets, while insulin-deficient islets showed normal expression.
- In laser-captured islets, RNA levels were elevated for HLA-A (1.9 ± 0.14-fold), HLA-B (2.15 ± 0.16-fold), HLA-C (2.02 ± 0.09-fold), and β2-microglobulin (2.07-fold) in the DiViD cohort; nPOD showed similar but less marked trends.
- A non-classical HLA molecule, HLA-F, was also upregulated, by 1.71 ± 0.04-fold at the RNA level in DiViD and confirmed at the protein level.
- STAT1 correlated positively with HLA-ABC expression, with Spearman’s r = 0.5454, p < 0.0001; by contrast, NLRC5 did not correlate with HLA-ABC hyperexpression (p = 0.4504).
- HLA-ABC hyperexpression was seen in patients with disease duration up to 11 years and then declined; the proportion of insulin-containing islets hyperexpressing HLA-ABC decreased with duration (r = –0.883, p < 0.0001).
Methods
- Pancreas tissue from 26 type 1 diabetes patients with residual insulin-containing islets and 17 control individuals was analyzed across three cohorts: nPOD, DiViD, and a UK collection.
- FFPE and frozen sections were stained for HLA class I isoforms, STAT1, NLRC5, β2-microglobulin, and islet hormones; islets from nPOD and DiViD were also laser-capture microdissected for RNA extraction.
- Gene-expression arrays were used for RNA analysis, and statistical testing used t tests or Satterthwaite corrected two-sample tests, with p < 0.05 as the significance threshold.
Limitations
- The paper states that the disease process in living patients cannot be studied non-invasively, so conclusions rely on tissue recovered after death or by pancreas biopsy.
- The authors note that HLA-I hyperexpression had previously been studied in relatively few patients, and that earlier RNA studies were limited; this paper addresses that by using more cohorts and samples.
- Evident from the text: the RNA analyses were performed on pooled, laser-captured islets that did not distinguish hyperexpressing from normal islets, or insulin-containing from insulin-deficient islets at collection, which limits cell-level specificity of the transcript data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 16 Not checked · 36 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, it was strongly associated with increased STAT1 expression in all three cohorts.”
- Also stated in: § Signal transducer and activator of transcription 1 (STAT1) expression correlates positively with HLA-ABC hyperexpression in type 1 diabetes · boosted
“This revealed a striking positive correlation between STAT1 and HLA-ABC expression (Fig. 6b, overall Spearman’s r = 0.5454, p < 0.0001).”
§ Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes > Abstract > Results
boostedstates an associationn = 7- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Signal transducer and activator of transcription 1 (STAT1) expression correlates positively with HLA-ABC hyperexpression in type 1 diabetes · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Islet hyperexpression of HLA-ABC was not confined solely to beta cells, but occurred in all islet endocrine cells (Fig. 1, ESM Fig. 1b).”
§ Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes > Results > Lobular hyperexpression of HLA-A, -B and -C (HLA-ABC) in type 1 diabetes
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“it was observed that a non-classical HLA, HLA-F, was also upregulated (by 1.71 ± 0.04-fold) when analysed across all probe sets (Fig. 4a).”
§ Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes > Results > HLA-F expression is also elevated in the ICIs of individuals with recent-onset type 1 diabetes
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Quantification yielded mean ± SEM increases of 1.9 ± 0.14-fold, 2.15 ± 0.16-fold, 2.02 ± 0.09-fold for HLA-A, -B and -C, respectively, and 2.07-fold for β2M.”
§ Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes > Results > Expression of RNA transcripts encoding HLA or β2M in laser-captured, microdissected islets
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Consistent with this, the most pronounced rise was seen in islets harvested by laser-capture microdissection from the six DiViD patients (p = 0.0263; Fig. 6d, ESM Fig. 7), who were studied very close to disease onset.”
§ Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes > Results > Signal transducer and activator of transcription 1 (STAT1) expression correlates positively with HLA-ABC hyperexpression in type 1 diabetes
plainstates an associationn = 6- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
23 more claims
Create a free account to see all 52 claims and to verify the 34 references still open.
- It may state two separate claims as one. 17
- Probably not a substantial claim. 8
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603 · cited 1×
“Raw signal intensity values from all arrays were Robust Multichip Average (RMA) background corrected, quantile normalized, median polish summarized, and log2transformed [25-27].”
MethodAtkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931 · cited 3×
“Despite these limitations, a consensus model has emerged in which type 1 diabetes is envisaged to result from the selective destruction of beta-cells by immune cells infiltrating the islets of Langerhans [1-3, 8, 9].”
Self-citationMicroarray data normalization and transformation
Quackenbush, J. (2002) · Nature Genetics · doi:10.1038/ng1032 · Cited by 1,975 · cited 1×
“Raw signal intensity values from all arrays were Robust Multichip Average (RMA) background corrected, quantile normalized, median polish summarized, and log2transformed [25-27].”
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854 · cited 2×
“Despite these limitations, a consensus model has emerged in which type 1 diabetes is envisaged to result from the selective destruction of beta cells by immune cells infiltrating the islets of Langerhans [1–3, 8, 9].”
A Model-Based Background Adjustment for Oligonucleotide Expression Arrays
Wu, Z., Irizarry, R. A., Gentleman, R., Martinez-Murillo, F., & Spencer, F. (2004) · Journal of the American Statistical Association · doi:10.1198/016214504000000683 · Cited by 1,716 · cited 1×
“Raw signal-intensity values from all arrays were robust multichip average background corrected, quantile normalised, median polish summarised and log 2 transformed [25–27].”
Bottazzo, G. F., Dean, B. M., McNally, J. M., MacKay, E. H., Swift, P. G. F., & Gamble, D. R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508083130604 · Cited by 932 · cited 1×
“This could be achieved in several ways, including via the up-regulated expression of the major histocompatibility complex (HLA class I molecules) [15-17].”
Analysis of islet inflammation in human type 1 diabetes
Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03860.x · Cited by 712 · cited 5×
“1), while insulin-deficient islets (IDIs) displayed normal expression.”
InfluentialSelf-citationCoppieters, K. T., Dotta, F., Amirian, N., Campbell, P. D., Kay, T. W. H., Atkinson, M. A., Roep, B. O., & von Herrath, M. G. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111187 · Cited by 672 · cited 2×
“It is also likely, however, that beta cells are complicit in these events by aberrantly processing and presenting cellular antigens, thereby becoming visible to autoreactive CD8 Tcells [14].”
Self-citationFoulis, A. K., Liddle, C. N., Farquharson, M. A., Richmond, J. A., & Weir, R. S. (1986) · Diabetologia · doi:10.1007/bf00452061 · Cited by 469 · cited 2×
“Hence, deductions regarding pathogenic processes are made from analyses of tissue recovered either after death or by pancreas biopsy in living individuals [4–7].”
NLR family member NLRC5 is a transcriptional regulator of MHC class I genes
Meissner, T. B., Li, A., Biswas, A., Lee, K.-H., Liu, Y.-J., Bayir, E., Iliopoulos, D., van den Elsen, P. J., & Kobayashi, K. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008684107 · Cited by 447 · cited 1×
“NLR familyCARDdomain containing 5 (NLRC5) expression does not correlate with HLA-ABC hyperexpression In order to understand the factors that might drive islet HLA-I hyperexpression in type 1 diabetes, we studied NLRC5, a known transcriptional regulator of HLA-ABC and β2M [31].”
Cited by
DiMeglio, L. A., Evans-Molina, C., & Oram, R. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31320-5 · Cited by 1,561
Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., Jacobsen, L. M., Schatz, D. A., & Lernmark, Å. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.16 · Cited by 1,475
Zhu, Y., Piehowski, P. D., Zhao, R., Chen, J., Shen, Y., Moore, R. J., Shukla, A. K., Petyuk, V. A., Campbell-Thompson, M., Mathews, C. E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03367-w · Cited by 587
Self-citationThe heterogeneous pathogenesis of type 1 diabetes mellitus
Ilonen, J., Lempainen, J., & Veijola, R. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0254-y · Cited by 494
Autoreactive T cells in type 1 diabetes
Pugliese, A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94549 · Cited by 358
“This observation was confirmed with various methodologies in multiple patient cohorts (26) (Figure 2).”
ResultSelf-citationTargeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes
Thompson, P. J., Shah, A., Ntranos, V., Van Gool, F., Atkinson, M., & Bhushan, A. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.021 · Cited by 353
Self-citationJAK/STAT – Emerging Players in Metabolism
Dodington, D. W., Desai, H. R., & Woo, M. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.11.001 · Cited by 275
Marroqui, L., Dos Santos, R. S., Op de beeck, A., Coomans de Brachène, A., Marselli, L., Marchetti, P., & Eizirik, D. L. (2017) · Diabetologia · doi:10.1007/s00125-016-4201-3 · Cited by 203
Kaestner, K. H., Powers, A. C., Naji, A., HPAP Consortium, & Atkinson, M. A. (2019) · Diabetes · doi:10.2337/db19-0058 · Cited by 173
“More recent studies revealed that cells of the adaptive immune response, reactive to b-cell antigens, are present within the insulitic lesion (14–16) along with a series of local changes in pathology including hyperexpression of HLA class I molecules on b-cells (17), hyaluronan deposition within islets (18), and aberr…”
BackgroundSelf-citationThe Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer
Giuliani, C., Bucci, I., & Napolitano, G. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00471 · Cited by 158
Type 1 diabetes mellitus: much progress, many opportunities
Powers, A. C. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142242 · Cited by 152
The diabetes pandemic and associated infections: suggestions for clinical microbiology
Toniolo, A., Cassani, G., Puggioni, A., Rossi, A., Colombo, A., Onodera, T., & Ferrannini, E. (2018) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000155 · Cited by 178
“As indirect evidence for enterovirus infection, viral signatures such as interferon and major histocompatibility complex class-I (MHC-I) hyperexpression have been found in T1DM [128].”
BackgroundRussell, M. A., Redick, S. D., Blodgett, D. M., Richardson, S. J., Leete, P., Krogvold, L., Dahl-Jørgensen, K., Bottino, R., Brissova, M., Spaeth, J. M., et al. (2019) · Diabetes · doi:10.2337/db18-0686 · Cited by 142
“These results were consistent with immunohistochemical studies on pancreata from donors with type 1 diabetes (5,6,9,29).”
BackgroundResultInfluentialSelf-citationColli, M. L., Ramos-Rodríguez, M., Nakayasu, E. S., Alvelos, M. I., Lopes, M., Hill, J. L. E., Turatsinze, J.-V., Coomans de Brachène, A., Russell, M. A., Raurell-Vila, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16327-0 · Cited by 140
Self-citationPersistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus
Nekoua, M. P., Alidjinou, E. K., & Hober, D. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00688-1 · Cited by 162
Atkinson, M. A., & Mirmira, R. G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.018 · Cited by 145
Self-citationShields, B. M., McDonald, T. J., Oram, R., Hill, A., Hudson, M., Leete, P., Pearson, E. R., Richardson, S. J., Morgan, N. G., Hattersley, A. T., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0465 · Cited by 120
Self-citationPartners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis
Toren, E., Burnette, K., Banerjee, R. R., Hunter, C. S., & Tse, H. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.756548 · Cited by 124
Inshaw, J. R. J., Cutler, A. J., Crouch, D. J. M., Wicker, L. S., & Todd, J. A. (2019) · Diabetes Care · doi:10.2337/dc19-0803 · Cited by 116
Yeh, W.-I., Seay, H. R., Newby, B. N., Posgai, A. L., Moniz, F. B., Michels, A. W., Mathews, C. E., Bluestone, J. A., & Brusko, T. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01313 · Cited by 112
Self-citationType 1 Diabetes Candidate Genes Linked to Pancreatic Islet Cell Inflammation and Beta-Cell Apoptosis
Størling, J., & Pociot, F. (2017) · Genes · doi:10.3390/genes8020072 · Cited by 114
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
Dunne, J. L., Richardson, S. J., Atkinson, M. A., Craig, M. E., Dahl-Jørgensen, K., Flodström-Tullberg, M., Hyöty, H., Insel, R. A., Lernmark, Å., Lloyd, R. E., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4811-7 · Cited by 95
Self-citationAvrahami, D., Wang, Y. J., Schug, J., Feleke, E., Gao, L., Liu, C., Naji, A., Gläser, B., & Kaestner, K. H. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101057 · Cited by 105
“Interestingly, we detected hyperexpression of the HLA class I antigens HLA-A and HLA-B as well as that of B2M (b2microglobulin), the second component of MHC class I complex, among diabetic b-cells (Figure S2B), possibly as a response to proinflammatory conditions, supported by the upregulation of TNF-a signalling in T…”
BackgroundInterferon alpha: The key trigger of type 1 diabetes
Lombardi, A., Tsomos, E., Hammerstad, S. S., & Tomer, Y. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.08.003 · Cited by 103
Human islet T cells are highly reactive to preproinsulin in type 1 diabetes
Anderson, A. M., Landry, L. G., Alkanani, A. K., Pyle, L. L., Powers, A. C., Atkinson, M. A., Mathews, C. E., Roep, B. O., Michels, A. W., & Nakayama, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107208118 · Cited by 102
Self-citationBender, C., Rodriguez-Calvo, T., Amirian, N., Coppieters, K. T., & von Herrath, M. G. (2020) · Science Advances · doi:10.1126/sciadv.abc5586 · Cited by 90
“This enrichment of antigen-specific CD8+ T cells suggests that they become attracted to their key antigen in ICIs during disease development, possibly due to the previously documented up-regulation of major histocompatibility complex (MHC) class I (14) and accumulation of proinsulin (15), both hallmarks of T1D pathoge…”
Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD Mice
Trivedi, P., Graham, K. L., Scott, N. A., Jenkins, M. R., Majaw, S., Sutherland, R. M., Fynch, S., Lew, A. M., Burns, C. J., Krishnamurthy, B., et al. (2017) · Diabetes · doi:10.2337/db16-1250 · Cited by 96
“This has recently been shown to be associated with high levels of phosphorylated signal transducer and activator of transcription (p-STAT) 1 (8).”
BackgroundRichardson, S. J., & Morgan, N. G. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.07.006 · Cited by 112
Self-citationDelineating mouse β-cell identity during lifetime and in diabetes with a single cell atlas
Hrovatin, K., Bastidas-Ponce, A., Bakhti, M., Zappia, L., Büttner, M., Salinno, C., Sterr, M., Böttcher, A., Migliorini, A., Lickert, H., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00876-x · Cited by 86
Abnormal islet sphingolipid metabolism in type 1 diabetes
Holm, L. J., Krogvold, L., Hasselby, J. P., Kaur, S., Claessens, L. A., Russell, M. A., Mathews, C. E., Hanssen, K. F., Morgan, N. G., Koeleman, B. P. C., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4614-2 · Cited by 90
Self-citationEnvironmental Factors Associated With Type 1 Diabetes
Esposito, S., Toni, G., Tascini, G., Santi, E., Berioli, M. G., & Principi, N. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00592 · Cited by 106
Endocrine Disrupting Chemicals and Type 1 Diabetes
Predieri, B., Bruzzi, P., Bigi, E., Ciancia, S., Madeo, S. F., Lucaccioni, L., & Iughetti, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082937 · Cited by 95
“T1D onset results from the destruction of the pancreatic β-cells due to both cellular infiltration [11,12] and autoimmune responses [13].”
BackgroundApaolaza, P. S., Balcacean, D., Zapardiel-Gonzalo, J., Nelson, G., Lenchik, N., Akhbari, P., Gerling, I., Richardson, S. J., Rodriguez-Calvo, T., & nPOD-Virus Group (2021) · Science Advances · doi:10.1126/sciadv.abd6527 · Cited by 83
Self-citationIFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells
Coomans de Brachène, A., Dos Santos, R. S., Marroqui, L., Colli, M. L., Marselli, L., Mirmira, R. G., Marchetti, P., & Eizirik, D. L. (2018) · Diabetologia · doi:10.1007/s00125-017-4536-4 · Cited by 81
“The overexpression of major histocompatibility complex (MHC) class I in pancreatic islets, probably secondary to local interferon-α (IFNα) production, is a key feature in the pathogenesis of type 1 diabetes [1, 2].”
The Human Islet: Mini-Organ With Mega-Impact
Walker, J. T., Saunders, D. C., Briššová, M., & Powers, A. C. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab010 · Cited by 97
Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells
Leite, N. C., Sintov, E., Meissner, T. B., Brehm, M. A., Greiner, D. L., Harlan, D. M., & Melton, D. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107894 · Cited by 78
“Following IFNg (Richardson et al., 2016) but not by thap treatment alone, iPSC-b and iPSC-a cells upregulated HLA class I (HLA-ABC) and other immunoregulatory molecules, includingprogrammeddeath-ligand1 (PD-L1) andFascell surface death receptor (FasR) (see Figures S1G–S1P, 1E, and 1F).”
BackgroundEbrahimi, A. G., Hollister-Lock, J., Sullivan, B. A., Tsuchida, R., Bonner-Weir, S., & Weir, G. C. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.02.002 · Cited by 73
“Recent studies made a strong case for beta cells with class 1 antigen being generally associated with lymphocytic infiltration [73,74].”
BackgroundIfie, E., Russell, M. A., Dhayal, S., Leete, P., Sebastiani, G., Nigi, L., Dotta, F., Marjomäki, V., Eizirik, D. L., Morgan, N. G., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4704-1 · Cited by 75
Self-citationXu, G., Grimes, T., Grayson, T. B., Chen, J., Thielen, L. A., Tse, H. M., Li, P., Kanke, M., Lin, T., Schepmoes, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28826-3 · Cited by 84
The Emerging Roles of Human Leukocyte Antigen-F in Immune Modulation and Viral Infection
Lin, A., & Yan, W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00964 · Cited by 70
“However, cell surface HLA-F expression has been detected on activated B cells, T cells, NK cells, Epstein-Barr virus (EBV)transformed B lymphoblastoid cell lines (38), virus-infected cells (21, 27), and on other tissues such as insulin-containing islets (39) and first- and second-trimester migratory and invasive extra…”
BackgroundHuman Endogenous Retroviruses and Type 1 Diabetes
Levet, S., Charvet, B., Bertin, A., Deschaumes, A., Perron, H., & Hober, D. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1256-9 · Cited by 75
Szymczak, F., Colli, M. L., Mamula, M. J., Evans‐Molina, C., & Eizirik, D. L. (2021) · Science Advances · doi:10.1126/sciadv.abd7600 · Cited by 79
Interferons are key cytokines acting on pancreatic islets in type 1 diabetes
de Brachène, A. C., Alvelos, M. I., Szymczak, F., Zimath, P. L., Castela, Â., de Souza, B. M., Roca-Rivada, A., Marín‐Cañas, S., Yi, X., Beeck, A. O. D., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06106-7 · Cited by 79
“…12 genes related to the immune and anti-viral response that are highly expressed at the protein level in pancreatic islets from donors with type 1 diabetes when compared with control individuals [43, 44, 47–49], and investigated the impact of the different cytokines on their expression (Fig.”
Self-citationThe Genetic Architecture of Type 1 Diabetes
Jerram, S. T., & Leslie, R. D. (2017) · Genes · doi:10.3390/genes8080209 · Cited by 94
“Class 1 hyperexpression (HLA plus beta 2 microglobulin upregulated) plus STAT1 expression in islets of patients with T1D are consistent with an interferon effect (though importantly it affects islets both with insulitis and those without insulitis) [47,55].”
BackgroundPancreatic islet inflammation: an emerging role for chemokines
Collier, J. J., Sparer, T. E., Karlstad, M. D., & Burke, S. J. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0042 · Cited by 73
The beta cell-immune cell interface in type 1 diabetes (T1D)
James, E. A., Joglekar, A. V., Linnemann, A. K., Russ, H. A., & Kent, S. C. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101809 · Cited by 82
“Type I IFN is also expressed in pancreatic islets from people with T1D [58,75,84 e 88] and laser-captured islets obtained from donors with recent onset T1D show an increase in IFN-stimulated genes [89,90].”
BackgroundType 1 diabetes and viral infections: What is the relationship?
Principi, N., Berioli, M. G., Bianchini, S., & Esposito, S. (2017) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.09.003 · Cited by 84
Morgan, N. G., & Richardson, S. J. (2018) · Diabetologia · doi:10.1007/s00125-018-4731-y · Cited by 74
Self-citationJaveed, N., Her, T. K., Brown, M., Vanderboom, P. M., Rakshit, K., Egan, A. M., Vella, A. V., Lanza, I. R., & Matveyenko, A. V. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109613 · Cited by 69
Kallionpää, H., Somani, J., Tuomela, S., Ullah, U., de Albuquerque, R., Lönnberg, T., Komsi, E., Siljander, H., Honkanen, J. K., Härkönen, T., et al. (2019) · Diabetes · doi:10.2337/db19-0287 · Cited by 71
Protecting Stem Cell Derived Pancreatic Beta-Like Cells From Diabetogenic T Cell Recognition
Castro-Gutierrez, R., Alkanani, A., Mathews, C. E., Michels, A., & Russ, H. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.707881 · Cited by 59
Self-citationEnteroviruses and Type 1 Diabetes: Multiple Mechanisms and Factors?
Lloyd, R. E., Tamhankar, M., & Lernmark, Å. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042320-015952 · Cited by 59
What the HLA-I!—Classical and Non-classical HLA Class I and Their Potential Roles in Type 1 Diabetes
Wyatt, R. C., Lanzoni, G., Russell, M. A., Gerling, I., & Richardson, S. J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1245-z · Cited by 66
Self-citationThe IGFBP3/TMEM219 pathway regulates beta cell homeostasis
D’Addio, F., Maestroni, A., Assi, E., Nasr, M. B., Amabile, G., Usuelli, V., Loretelli, C., Bertuzzi, F., Antonioli, B., Cardarelli, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28360-2 · Cited by 62
Self-citationType I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment
Newby, B. N., & Mathews, C. E. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00232 · Cited by 62
Self-citationLimited extent and consequences of pancreatic SARS-CoV-2 infection
van der Heide, V., Jangra, S., Cohen, P., Rathnasinghe, R., Aslam, S., Aydillo, T., Geanon, D., Handler, D., Kelley, G., Lee, B. H., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110508 · Cited by 60
“…cell types is noteworthy because it is accompanied by modestly elevated expression in non-infected cells, a ‘‘bystander effect’’ consistent with an ISG response and reminiscent of the histopathological T1D hallmark of HLA-ABC hyperexpression in INS-containing islets (Richardson et al., 2016).”
Self-citationA transcriptional cross species map of pancreatic islet cells
Tritschler, S., Thomas, M., Böttcher, A., Ludwig, B., Schmid, J., Schubert, U., Kemter, E., Wolf, E., Lickert, H., & Theis, F. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101595 · Cited by 70
“Increased levels of MHC class I were suggested to contribute to aberrant antigen presentation and autoimmune-mediated b-cell destruction [41].”
BackgroundGonzález‐Moro, I., Olazagoitia‐Garmendia, A., Colli, M. L., Cobo‐Vuilleumier, N., Postler, T. S., Marselli, L., Marchetti, P., Ghosh, S., Gauthier, B. R., Eizirik, D. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914353117 · Cited by 67
The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α
Chandra, V., Ibrahim, H., Halliez, C., Prasad, R. B., Vecchio, F., Dwivedi, O. P., Kvist, J., Balboa, D., Saarimäki‐Vire, J., Montaser, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34069-z · Cited by 63
“hallmarks in diabetic β-cells(24), we observed that upon IFNα treatment, HLA-A, HLA-B, HLA-C and HLA-E genes were strongly up-regulated in WT cells, but unchanged in TYK2 KO cells (Supplemental Figure 6B).”
BackgroundPancreas Pathology During the Natural History of Type 1 Diabetes
Calvo, T. R., Richardson, S. J., & Pugliese, A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1084-3 · Cited by 62
Self-citationScherm, M. G., Wyatt, R. C., Serr, I., Anz, D., Richardson, S. J., & Daniel, C. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101565 · Cited by 53
“A phenomenon not seen in donors without diabetes [154,209].”
BackgroundSelf-citationEnterovirus infection and type 1 diabetes: unraveling the crime scene
Calvo, T. R. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13223 · Cited by 65
New Insights Into the Role of Autoreactive CD8 T Cells and Cytokines in Human Type 1 Diabetes
Bender, C., Rajendran, S. H., & von Herrath, M. G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.606434 · Cited by 57
Viruses and Type 1 Diabetes: From Enteroviruses to the Virome
Isaacs, S. R., Foskett, D. B., Maxwell, A. J., Ward, E. J., Faulkner, C. L., Luo, J. Y. X., Rawlinson, W. D., Craig, M. E., & Kim, K. W. (2021) · Microorganisms · doi:10.3390/microorganisms9071519 · Cited by 59
The Immunoproteasome: An Emerging Target in Cancer and Autoimmune and Neurological Disorders
Zerfas, B. L., Maresh, M. E., & Trader, D. J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01226 · Cited by 57
Blanter, M., Sork, H., Tuomela, S., & Flodström‐Tullberg, M. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1192-8 · Cited by 59
Carré, A., Richardson, S. J., Larger, É., & Mallone, R. (2020) · Diabetologia · doi:10.1007/s00125-020-05298-y · Cited by 57
“ForHLA-I hyperexpression on beta cells [8, 9] suggests a role for CD8 T cells.”
BackgroundSelf-citationCirculating Sphingolipids in Insulin Resistance, Diabetes and Associated Complications
Hammad, S. M., & Lopes-Virella, M. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814015 · Cited by 56
“The ganglioside pattern has been shown to be of importance to determine beta cell susceptibility to viral infections [66,94–100].”
Disrupted RNA editing in beta cells mimics early-stage type 1 diabetes
Knebel, U. E., Peleg, S., Dai, C., Cohen‐Fultheim, R., Jonsson, S., Poznyak, K., Israeli, M., Zamashanski, L., Gläser, B., Levanon, E. Y., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.11.011 · Cited by 52
Environmental Triggering of Type 1 Diabetes Autoimmunity
Houeiss, P., Luce, S., & Boîtard, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.933965 · Cited by 61
100 YEARS OF INSULIN: Pancreas pathology in type 1 diabetes: an evolving story
Richardson, S. J., & Pugliese, A. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0358 · Cited by 55
Self-citationInsulitis in human diabetes: a histological evaluation of donor pancreases
Lundberg, M., Seiron, P., Ingvast, S., Korsgren, O., & Skog, O. (2016) · Diabetologia · doi:10.1007/s00125-016-4140-z · Cited by 51
“In addition, other morphological hallmarks for type 1 diabetes were evaluated in the type 2 diabetic pancreases, such as islets without beta cells [2, 12, 13] or the presence of HLA class I hyperstaining in the islets [14, 15].”
BackgroundA role for both HLA-F and HLA-G in reproduction and during pregnancy?
Persson, G., Jørgensen, N., Nilsson, L. L., Andersen, L. H. J., & Hviid, T. V. F. (2019) · Human Immunology · doi:10.1016/j.humimm.2019.09.006 · Cited by 46
Advances in Knowledge of Candidate Genes Acting at the Beta-Cell Level in the Pathogenesis of T1DM
Pang, H., Luo, S., Huang, G., Xia, Y., Xie, Z., & Zhou, Z. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00119 · Cited by 52
“Overexpression ofMHC-| can render insulin-producing beta-cells more sensitive to attack by cytotoxic T lymphocytes, and ER stress is associated with alterations in mRNA splicing and the production of abnormal proteins, which may serve as immunogenic antigens (9, 48).”
BackgroundType 1 diabetes mellitus: Inflammation, mitophagy, and mitochondrial function
Blagov, A. V., Summerhill, V. I., Sukhorukov, V. N., Popov, M. A., Grechko, A. V., & Orekhov, A. N. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.07.002 · Cited by 49
Molecular Pathways for Immune Recognition of Preproinsulin Signal Peptide in Type 1 Diabetes
Kronenberg‐Versteeg, D., Eichmann, M., Russell, M. A., de Ru, A., Hehn, B., Yusuf, N., van Veelen, P. A., Richardson, S. J., Morgan, N. G., Lemberg, M. K., et al. (2018) · Diabetes · doi:10.2337/db17-0021 · Cited by 48
Self-citationBenkahla, M. A., Sabouri, S., Kiosses, W. B., Rajendran, S. H., Quesada‐Masachs, E., & von Herrath, M. G. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102628 · Cited by 43
Inflammation versus regulation: how interferon-gamma contributes to type 1 diabetes pathogenesis
George, D. J. D., Ge, T., Krishnamurthy, B., Kay, T. W. H., & Thomas, H. E. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1205590 · Cited by 50
“Increased HLA-I expression on ß cells in human T1D correlated with upregulation of STAT1, the transcription factor downstream of IFN-γ signaling (Richardson et al., 2016).”
BackgroundKrogvold, L., Genoni, A. P., Puggioni, A., Campani, D., Richardson, S. J., Flaxman, C. S., Edwin, B., Buanes, T. A., Dahl‐Jørgensen, K., & Toniolo, A. (2022) · Diabetologia · doi:10.1007/s00125-022-05779-2 · Cited by 50
“At the time of clinical onset, IFN-stimulated genes (ISGs) are expressed in the islets [5], HLA class I is hyperexpressed [4, 6] and memory CD8 T lymphocytes are among the infiltrating cells [7].”
BackgroundSelf-citationModeling human T1D-associated autoimmune processes
Maharlooei, M. K., Madley, R., Borsotti, C., Ferreira, L. M. R., Sharp, R. C., Brehm, M. A., Greiner, D. L., Parent, A. V., Anderson, M. S., Sykes, M., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101417 · Cited by 47
Szymczak, F., Alvelos, M. I., Marín‐Cañas, S., Castela, Â., Demine, S., Colli, M. L., Beeck, A. O. D., Thomaidou, S., Marselli, L., Zaldumbide, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn5732 · Cited by 44
Islet–immune interactions in type 1 diabetes: the nexus of beta cell destruction
Peters, L. D., Posgai, A. L., & Brusko, T. M. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13349 · Cited by 41
Carré, A., Samassa, F., Zhou, Z., Perez-Hernandez, J., Lekka, C., Manganaro, A., Oshima, M., Liao, H., Parker, R. S., Nicastri, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55908-9 · Cited by 44
“IFN-α 8 and IFN-stimulated gene expression 11 colocalize with HLA-I hyper-expression, which is a histopathological hallmark of T1D in insulin (INS)-containing islets 12 .”
Self-citationTuomela, K., & Levings, M. K. (2024) · Diabetologia · doi:10.1007/s00125-023-06076-2 · Cited by 39
“Beta cells themselves can express HLA class I and II under inflammatory conditions [68, 69], although likely at lower levels than on APCs, and so TCR-like CARs may be best suited for APC-based activation.”
Type I interferons as key players in pancreatic β-cell dysfunction in type 1 diabetes
Marroquí, L., Perez-Serna, A. A., Babiloni-Chust, I., & dos Santos, R. S. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.011 · Cited by 39
β-Cell autophagy in the pathogenesis of type 1 diabetes
Muralidharan, C., & Linnemann, A. K. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00151.2021 · Cited by 39
Jean-Baptiste, V. S. E., Xia, C., Clare-Salzler, M. J., & Horwitz, M. S. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.06.014 · Cited by 39
“…with diabetes), the Diabetes Virus Detection study, and from a collection of recent-onset T1D samples from the United Kingdom, Richardson et al. demonstrated that classical and non-classical MHC-I hyper-expression is pertinent to patients with T1D but not the controls (Richardson et al., 2016).”
BackgroundInfluentialLiu, Z., Zhao, Y. Q., Fang, J., Cui, R., Xiao, Y., & Xu, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.18591 · Cited by 37
“Preliminary studies revealed a strong correlation between STAT1 and HLA-ABC expression in type 1 diabetes [16].”
BackgroundPotential role of type I interferon in the pathogenic process leading to type 1 diabetes
Qaisar, N., Jurczyk, A., & Wang, J. P. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000399 · Cited by 39
A Century-long Journey From the Discovery of Insulin to the Implantation of Stem Cell–derived Islets
Ramzy, A., Belmonte, P. J., Braam, M. J. S., Ida, S., Wilts, E. M., Levings, M. K., Rezania, A., & Kieffer, T. J. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac021 · Cited by 34
Thompson, P. J., Pipella, J., Rutter, G. A., Gaisano, H. Y., & Santamaría, P. (2023) · Diabetologia · doi:10.1007/s00125-023-05970-z · Cited by 42
Yeo, L., Pujol‐Autonell, I., Baptista, R., Eichmann, M., Kronenberg‐Versteeg, D., Heck, S., Dolton, G. M., Sewell, A. K., Härkönen, T., Mikk, M.-L., et al. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13391 · Cited by 38
Huang, J., Peng, J., Pearson, J. A., Efthimiou, G., Hu, Y., Tai, N., Xing, Y., Zhang, L., Gu, J., Jiang, J., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00590-8 · Cited by 38
Shapiro, M. R., Yeh, W.-I., Longfield, J. R., Gallagher, J., Infante, C. M., Wellford, S., Posgai, A. L., Atkinson, M. A., Campbell‐Thompson, M., Lieberman, S. M., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02180 · Cited by 34
Self-citationFrom Disease and Patient Heterogeneity to Precision Medicine in Type 1 Diabetes
den Hollander, N. H. M., & Roep, B. O. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.932086 · Cited by 34
Beta cell dysfunction occurs independently of insulitis in type 1 diabetes pathogenesis
Huber, M. K., Widener, A. E., Cuaycal, A. E., Smurlick, D., Butterworth, E. A., Lenchik, N. I., Chen, J., Beery, M. L., Hiller, H., Verney, E., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116174 · Cited by 30
“54,55 The remaining markers with altered expression are directly involved in glucose metabolism.”
Self-citationEnteroviruses and T1D: Is It the Virus, the Genes or Both which Cause T1D
Geravandi, S., Liu, H., & Maedler, K. (2020) · Microorganisms · doi:10.3390/microorganisms8071017 · Cited by 36
“Histological analyses of the human T1D pancreas show all, viral capsid VP1, IFNα, the major cytokine induced by viral infection, and HLA I expressed in or within the islet proximity [52,53].”
BackgroundInfluentialMolecular Footprints of the Immune Assault on Pancreatic Beta Cells in Type 1 Diabetes
Colli, M. L., Szymczak, F., & Eizirik, D. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.568446 · Cited by 37
Elvira, B., Vandenbempt, V., Bauzá‐Martinez, J., Crutzen, R., Negueruela, J., Ibrahim, H., Winder, M. L., Brahma, M. K., Vekeriotaite, B., Martens, P.-J., et al. (2022) · Diabetes · doi:10.2337/db21-0443 · Cited by 32
The countdown to type 1 diabetes: when, how and why does the clock start?
Ziegler, A.-G. (2023) · Diabetologia · doi:10.1007/s00125-023-05927-2 · Cited by 30
Metadata
- Authors
- Richardson, S. J., Rodriguez-Calvo, T., Gerling, I. C., Mathews, C. E., Kaddis, J. S., Russell, M. A., Zeissler, M., Leete, P., Krogvold, L., Dahl-Jørgensen, K., von Herrath, M., Pugliese, A., Atkinson, M. A., & Morgan, N. G.
- Affiliations
- University of Exeter (GB)
- University of Tennessee Health Science Center (US)
- University of Florida Health (US)
- City Of Hope National Medical Center (US)
- Oslo University Hospital (NO)
- University of Miami (US)
- Corresponding author
- Richardson, Sarah J.
- Morgan, Noel G.
- ORCID
- Venue
- Diabetologia
- Published
- 2016-08-09
- Volume
- 59
- Issue
- 11
- Pages
- 2448-2458
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC5042874
- OpenAlex
- W2513957711
- Cited by
- 298
- References
- 43
- Citations by year
- 2026: 26 · 2025: 39 · 2024: 30 · 2023: 23 · 2022: 36 · 2021: 37 · 2020: 28 · 2019: 33 · 2018: 25 · 2017: 19 · 2016: 2
- FWCI
- 21.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Open Research Exeter (University of Exeter) (acceptedVersion)
- Figshare (submittedVersion)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
- Funders
- Seventh Framework Programme (261441)
- Diabetes Research & Wellness Foundation
- National Institutes of Health (UC4 DK104155)
- JDRF (JDRF 25-2012-516)
- South-Eastern Norway Regional Health Authority
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- type 1 diabetes, pancreatic beta cells, islets, STAT1, NLRC5, HLA-F, beta2-microglobulin, islet autoimmunity, immunopathogenesis, recent-onset type 1 diabetes, disease duration, islet gene expression, HLA-ABC
- MeSH terms
- Diabetes Mellitus, Type 1, Female, Fluorescent Antibody Technique, Humans, Immunohistochemistry, Insulin, Islets of Langerhans, Male, Pancreas, Histocompatibility Antigens Class I, STAT1 Transcription Factor, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.